Beam Therapeutics Inc.BEAMNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR-23.7%
5Y CAGR-83.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-23.7%/yr
Annual compound
5Y CAGR
-83.4%/yr
Recent acceleration
Percentile
P38
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 19.61 | -35.1% |
| 2024 | 30.24 | +521.8% |
| 2023 | 4.86 | -89.0% |
| 2022 | 44.07 | -51.5% |
| 2021 | 90.77 | -99.9% |
| 2020 | 156698.88 | +194.8% |
| 2019 | 53146.47 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |